Dr. Guillermo Garcia-Manero
Claim this profileM D Anderson Cancer Center
Expert in Myelodysplastic Syndrome
Studies Acute Myelogenous Leukemia
20 reported clinical trials
23 drugs studied
Area of expertise
1Myelodysplastic Syndrome
Global LeaderSF3B1 positive
U2AF1 positive
FLT3 positive
2Acute Myelogenous Leukemia
SF3B1 positive
U2AF1 positive
FLT3 positive
Affiliated Hospitals
Clinical Trials Guillermo Garcia-Manero is currently running
Canakinumab
for Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
This phase II trial studies how well canakinumab works for the treatment of low- or intermediate-risk myelodysplastic syndrome or chronic myelomonocytic leukemia. Canakinumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread.
Recruiting1 award Phase 29 criteria
CTX-712
for Acute Myeloid Leukemia and Myelodysplastic Syndrome
This trial is testing a new drug called CTX-712 to see if it is safe and effective for patients with certain types of blood cancer that have not responded to other treatments. The study will first determine the best dose and then check how well the drug works and if it is safe.
Recruiting1 award Phase 1 & 2
More about Guillermo Garcia-Manero
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Guillermo Garcia-Manero has experience with
- Azacitidine
- Venetoclax
- MBG453
- Canakinumab
- Luspatercept
- Ipilimumab
Breakdown of trials Guillermo Garcia-Manero has run
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Chronic Myelomonocytic Leukemia
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Guillermo Garcia-Manero specialize in?
Guillermo Garcia-Manero focuses on Myelodysplastic Syndrome and Acute Myelogenous Leukemia. In particular, much of their work with Myelodysplastic Syndrome has involved SF3B1 positive patients, or patients who are U2AF1 positive.
Is Guillermo Garcia-Manero currently recruiting for clinical trials?
Yes, Guillermo Garcia-Manero is currently recruiting for 7 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Guillermo Garcia-Manero has studied deeply?
Yes, Guillermo Garcia-Manero has studied treatments such as Azacitidine, Venetoclax, MBG453.
What is the best way to schedule an appointment with Guillermo Garcia-Manero?
Apply for one of the trials that Guillermo Garcia-Manero is conducting.
What is the office address of Guillermo Garcia-Manero?
The office of Guillermo Garcia-Manero is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.